Director
DIN: 01965692
Manjunath Narsinharao Kulkarni is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at HEALTHPRO PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01965692.Manjunath Narsinharao Kulkarni is currently involved in 2 different roles. Their most recent position is with FRONTAL LOBE TECHNOLOGY PRIVATE LIMITED as a Director. The first company Manjunath Narsinharao Kulkarni was appointed to as a director was HEALTHPRO PHARMACEUTICALS PRIVATE LIMITED. Manjunath Narsinharao Kulkarni is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Manjunath Narsinharao Kulkarni is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at HEALTHPRO PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 01965692.Manjunath Narsinharao Kulkarni is currently involved in 2 different roles. Their most recent position is with FRONTAL LOBE TECHNOLOGY PRIVATE LIMITED as a Director. The first company Manjunath Narsinharao Kulkarni was appointed to as a director was HEALTHPRO PHARMACEUTICALS PRIVATE LIMITED. Manjunath Narsinharao Kulkarni is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
3y 9m 1y 11m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| HEALTHPRO PHARMACEUTICALS PRIVATE LIMITED | Director | 14-Feb-2008 |
| FRONTAL LOBE TECHNOLOGY PRIVATE LIMITED | Director | 28-Apr-2024 |